Showing results (261-270 of 294) with videos related to
Sort By:
Pageof 30
Bone Marrow Transplantation|July 1, 1989
Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approachesR Arnold, C R Bartram, B Heinze, et al.Onkologie|June 1, 1979
[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study]M Dietrich, C Abt, R Arnold, et al.Haematologica|May 9, 2000
Geographic distribution of CDA-II: did a founder effect operate in Southern Italy?A Iolascon, V Servedio, R Carbone, et al.Blut|October 1, 1985
Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemophiliacs and other patients chronically substituted with blood productsV Erfle, R Hehlmann, W Mellert, et al.Blood|July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.The New England Journal of Medicine|May 9, 1991
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study GroupN Frickhofen, J P Kaltwasser, H Schrezenmeier, et al.Annals of Hematology|March 1, 1993
Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial resultsA Ganser, G Heil, K Kolbe, et al.Annals of Hematology|August 1, 1993
Interferon in chronic myeloid leukemia. A workshop reportM Griesshammer, R Hehlmann, A Hochhaus, et al.Blood|December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.Pageof 30